The campaign showcases root cause of Demodex blepharitis through creative representation of mischief-causing mites on patients’ eyelids.
Tarsus Pharmaceuticals, Inc. announced the launch of a...
Tarsus Pharmaceuticals, Inc. announced on July 25 that the U.S. Food and Drug Administration (FDA) approved XDEMVY™ (lotilaner ophthalmic solution) 0.25% for the treatment...